Healthcare News and Headlines
Healthcare News and Headlines
Healthcare Pulse
EMAIL DIGESTS
Daily
Every morning
Weekly
Tuesday recap
EMAIL DIGESTS
Daily
Every morning
Weekly
Tuesday recap
Positrigo, a Swiss developer of nuclear medical devices, has launched the BrainPET Accelerator Program in the United States, offering neurology practices a ready‑to‑operate brain PET solution. The program bundles a compact NeuroLF scanner, radiotracer logistics, regulatory assistance, reimbursement support, and remote image interpretation, eliminating the need for on‑site cyclotrons or extensive infrastructure. By delivering point‑of‑care functional imaging, the initiative targets clinics treating neurodegenerative and cognitive disorders. Positrigo aims to expand PET adoption beyond large hospitals and improve diagnostic confidence for neurologists.
Eko Health has partnered with Wayne General Hospital in Mississippi to roll out its SENSORA AI‑assisted cardiac detection platform across emergency and primary‑care units. The system pairs a digital stethoscope with FDA‑cleared AI that analyzes heart sounds in under a...
University of Missouri School of Medicine received a $4.6 million federal grant to launch a mobile pre‑hospital blood transfusion program in Columbia. The initiative aims to equip EMS crews with training and portable blood supplies, targeting rapid intervention for trauma victims,...
Bristol Myers Squibb reported that its antibody‑drug conjugate iza‑bren, licensed from Chinese partner SystImmune, achieved statistically significant improvements in progression‑free and overall survival versus chemotherapy in a Phase III trial for advanced triple‑negative breast cancer. The study, conducted in mainland China...
Sentara’s high‑volume TAVR center adopted the AI‑enabled DASI 3‑D planning platform to move beyond static CT measurements. The software dynamically simulates valve frame expansion, calcium deformation, and tissue interaction, allowing clinicians to test multiple valve sizes and depths before the...
Beta Bionics received an FDA warning letter citing failure to report serious adverse events, unreported software and cybersecurity changes, and hardware defects in its iLet Bionic Pancreas system. The agency highlighted delayed reporting of hypoglycemia and hyperglycemia incidents, a five‑minute...
India’s Generation X is projected to spend over $500 billion on goods and services by FY 30, according to RedSeer. The cohort’s spending will be led by preventive healthcare ($73 billion, 17% CAGR) and nutraceuticals ($20 billion, 25% CAGR). Premiumisation will also drive growth in...
The FDA granted 510(k) Class II clearance to Qure.ai’s qXR-Detect, adding six new chest‑X‑ray detection indications. The tool now flags findings across lung, pleura, mediastinum/hila & heart, bone, hardware and other regions, expanding the company’s U.S. portfolio to 26 FDA clearances. The clearance...
![[Comment] Impact of Adding Hormone Therapy to Postoperative Radiotherapy in Prostate Cancer](/cdn-cgi/image/width=1200,quality=75,format=auto,fit=cover/https://hixhlmpcokxhartfkpyi.supabase.co/storage/v1/object/public/images/thumbnails/f1452ec53e5201a4460c9aaf141538d3.webp)
Adding androgen deprivation therapy (ADT) to definitive radiotherapy improves overall survival for men with high‑risk prostate cancer, but its benefit when combined with postoperative radiotherapy (PORT) after prostatectomy is less clear. Randomised trials such as GETUG‑AFU 16, SPPORT, and the RADICALS‑HD...
The FDA announced it will default to a single pivotal trial for new drug applications, extending a practice long used in oncology and rare‑disease approvals. In 2024, 66% of new molecular entities were cleared based on one trial, signaling a...
Cisco Talos has identified a new threat cluster, UAT-10027, delivering a novel backdoor called Dohdoor that leverages DNS‑over‑HTTPS for command‑and‑control. The malware uses DLL side‑loading through legitimate Windows executables and drops a Cobalt Strike beacon that unhooks NTDLL calls to evade...
FDB’s Virginia Halsey introduced Model Context Protocols, a set of contractual guardrails for healthcare AI. The protocols require AI models to achieve a predefined confidence threshold before influencing clinical decisions and restrict their behavior to approved use‑cases. By embedding these...
Healthcare providers are increasingly dependent on multi‑layered vendor ecosystems to deliver AI, blockchain and IoT solutions, extending HIPAA liability to every downstream partner. The rise of “nth‑party” suppliers creates a hidden growth tax, delaying projects, inflating M&A costs, and exposing...
Smart D8, Dublin’s first health‑focused smart district, has opened its sixth open call for pilot projects, offering up to €10,000 per project to test innovations in real community settings. The 2026 call targets three priority themes—nutrition, social connectedness and workplace...
The latest episode of BioSpace’s Denatured podcast spotlights a growing partnership between ALS patients and pharmaceutical developers, featuring insights from EverythingALS founder Indu Navar and VectorY Therapeutics CMO Dr. Olga Uspenskaya. The discussion highlights how patient‑driven collaborations are accelerating trial timelines...
The U.S. Food and Drug Administration rejected a rare‑disease cell therapy that had already secured approval in Europe, despite earlier internal support from the agency. The decision comes under the FDA’s new leadership and has sparked debate over whether the...
The article updates the classic six‑factor framework for medical‑device commercialization, highlighting that Technological Feasibility, Market Size, and Reimbursement Potential remain top‑ranked but now demand AI integration, digital‑health ecosystem compatibility, and early payer engagement. Regulatory pathways have shifted dramatically with the...
Valant announced expanded AI Notes Assist, an AI‑driven documentation tool that now supports more than 100 behavioral health note templates, including SOAP, DAP, BIRP and custom formats. Integrated directly into Valant’s secure EHR, the solution generates structured notes from in‑person,...
ViVE 2026 in Los Angeles marked a decisive shift from digital ambition to operational accountability across the health ecosystem. Leaders emphasized that AI adoption now hinges on governance, measurable ROI, and clinician trust, while interoperability is being treated as core...
India’s healthcare landscape is rapidly pivoting from multi‑speciality hospitals to single‑speciality providers such as eye‑care, fertility and dialysis clinics. The shift is fueled by rising health‑insurance coverage, an ageing population and strong private‑capital appetite. While the overall market is projected...
Researchers have captured the fleeting i‑DNA structure inside living cells, showing it acts as a molecular switch for genes that drive cancer. The study demonstrates that i‑DNA formation and resolution are tightly timed during DNA replication, influencing gene expression and...
Continuous cardiac monitoring via wearable ECG devices is reshaping clinical trials and post‑market care. Recent studies show that 14‑day monitoring after cardiac surgery uncovered atrial fibrillation in 24% of patients, many of which were missed until three‑month follow‑ups. In epilepsy...
Signing bonuses remain a notable recruiting tool despite a cooling labor market, appearing in about 3% of U.S. job postings in December 2025—down from a 5.6% peak in 2022 but still above the 2019 average of 1.8%. Wage growth in...
Mark Cuban suggests treating hospitals like lean start‑ups, mirroring his Cost Plus Drugs model. He would enforce fixed, transparent margins, pay physicians above market rates, and strip away non‑essential infrastructure. Cuban also argues that AI‑driven contract automation could slash administrative...
Cara Medical announced that the U.S. FDA granted 510(k) clearance for its CARA System, a non‑invasive solution that creates patient‑specific 3‑D visualizations of the cardiac conduction system using CTA data. The platform pairs the CARA Metis™ Simulator for pre‑procedural mapping...
In 2025 the Centers for Medicare & Medicaid Services launched a voluntary Premium Stabilization Demonstration for Medicare Part D standalone drug plans to curb steep premium hikes and protect enrollment. GAO analysis showed that without the program, average premiums would have...
Digital imaging, especially 3D scanning and advanced radiography, is reshaping orthodontic diagnostics and treatment planning. These tools generate highly detailed virtual models and clearer X‑ray images while exposing patients to less radiation. The technology enables personalized treatment plans, real‑time monitoring,...
![[Comment] Oral GLP-1 Receptor Agonists: Competition for Efficacy and Tolerability](/cdn-cgi/image/width=1200,quality=75,format=auto,fit=cover/https://hixhlmpcokxhartfkpyi.supabase.co/storage/v1/object/public/images/thumbnails/ce10e510d7294b419a4a07dfad918da4.webp)
Oral GLP-1 receptor agonists have moved from injectable peptides to a tablet form, highlighted by oral semaglutide combined with the absorption enhancer SNAC. The formulation requires patients to fast overnight, take the dose with a small amount of water, and...
GlaxoSmithKline announced that China’s National Medical Products Administration has accepted the New Drug Application for linerixibat and placed it under priority review for treating cholestatic pruritus in primary biliary cholangitis (PBC). The filing is backed by the Phase III GLISTEN trial,...
Merck Animal Health announced that the U.S. FDA has approved Numelvi (atinvicitinib) for controlling pruritus linked to allergic dermatitis in dogs six months and older, with commercial availability slated for spring 2026. Numelvi is a second‑generation JAK inhibitor that demonstrates...
Researchers at the University of Edinburgh have created a luminescent reporter that detects granzyme A activity in stool samples, offering a rapid, non‑invasive marker of gut inflammation. In a trial of 150 specimens, the new assay combined with standard faecal calprotectin...
The FDA has rejected Regenxbio’s gene therapy for mucopolysaccharidosis type 2, citing a need for additional data that could postpone approval by years. This decision adds to at least four other recent rejections of cell or gene therapies targeting deadly rare...
Mahzi Therapeutics has administered the first dose of its investigational gene therapy MZ-1866 in the Phase I/II UNITE study for Pitt‑Hopkins syndrome. The open‑label, multicentre trial will enroll roughly 12 genetically confirmed patients across sites in Spain, Israel and the...
The Trump administration launched TrumpRx, a website aggregating manufacturer discounts on 43 brand‑name drugs and touting presidential credit for lower patient costs. Early analysis shows that 20 of the listed products already have cheaper generic versions, and the portal deliberately...
Sword Intelligence has launched its AI‑driven care‑operations platform in the UK, targeting NHS waiting‑list pressures. The solution automates triage, coordination, outreach and scheduling, freeing clinical capacity without major staffing or infrastructure upgrades. Simultaneously, the company is building one of Europe’s...
Researchers investigated how hydrothermal processing—both classic autoclave and microwave irradiation—affects the transverse relaxivity (r₂) of DyF₃ nanoparticle colloids. Using ¹H NMR at magnetic fields of 0.6 T, 3.65 T and 9.4 T, they found that autoclave‑treated samples exhibit the highest r₂ values, outperforming...
San Francisco and South San Francisco remain biotech hubs, employing over 113,700 workers according to a Cushman & Wakefield report. Although BioSpace job postings fell sharply in January, listings are now climbing, with ten companies actively hiring. Companies such as AbbVie, Amgen, Eli Lilly and Ideaya...
argenx announced topline Phase III ADAPT OCULUS data for Vyvgart (efgartigimod alfa + hyaluronidase‑qvfc) in adults with ocular myasthenia gravis. The trial met its primary endpoint, delivering a 4.04‑point improvement in Myasthenia Impairment Index PRO ocular scores versus 1.99 points for placebo at...
Whiddon, a leading residential aged‑care provider in NSW and southeast Queensland, has deployed Telstra Health’s centralised care‑planning platform across its 24 homes. The system enables real‑time, point‑of‑care documentation, family portals and mobile workflows, replacing legacy paper‑based processes. By achieving data...
The UK Medicines and Healthcare products Regulatory Agency (MHRA) is urging that AI innovation in healthcare be paired with robust regulation to safeguard patient safety and equity. Richard Stubbs, CEO of Health Innovation Yorkshire and Humber, highlighted the need for...
Governor Josh Shapiro convened a crisis response after Pennsylvania reported roughly 7.6 million birds infected with avian influenza, prompting a coordinated effort with the USDA and veterinary specialists to contain the outbreak and explore vaccine options. Simultaneously, H5N1 cases have emerged...
Sigma Healthcare reported double‑digit growth in its first‑half fiscal results, driven by the Chemist Warehouse network. Revenue rose 15% to $5.5 billion, normalised EBIT increased 18.7% to $582.9 million, and NPAT grew 19.2% to $392 million. Chemist Warehouse sales jumped 17.2% to $5.1 billion,...
An interdisciplinary team at University Health Network (UHN) received the Mission of Excellence Team Inventor of the Year Award for creating H.A.L.O., a remote patient monitoring system. Launched as a company in early 2025, H.A.L.O. now operates across 50 inpatient...
The Schroeder Ambulatory Centre (SAC), a $300 million private non‑profit facility in Richmond Hill, Ontario, has opened its doors with operating rooms, MRI, CT and GI endoscopy capabilities while awaiting full accreditation. It secured $14 million from the provincial government to deliver...
A congressional hearing highlighted that current Medicare GME funding formulas leave rural hospitals like Phelps Health struggling to bridge the $5‑$7 million gap between planning grants and accreditation costs. Hospital leaders argue that outdated per‑resident caps and rigid grant structures create...
Trillium Health Partners has launched a clinical AI application that automatically detects intracranial hemorrhage on head CT scans, flagging urgent cases in real time. The tool, sourced through Sectra Amplifier Services, also identifies midline shift, mass effect and skull fractures,...
Privia Health reported a robust 2025, with implemented providers rising 12.3% to 5,380 and attributed lives increasing 22.7% to 1.54 million. Practice collections grew 16.9% to $3.47 billion and adjusted EBITDA surged 38.8% to $125.5 million, delivering a 130% free‑cash‑flow conversion. The company...
OPKO Health reported a $369 million cash position for Q4 2025, driven by asset sales, BARDA funding and partnership payments. The company repurchased 34.6 million shares for $47 million and allocated $109 million to stock and convertible note buybacks. Diagnostics revenue dropped to $71.1 million, but...
Anika Therapeutics reported total revenue of $27.8 million for the quarter, a 6% year‑over‑year decline driven primarily by lower pricing in its OEM osteoarthritis pain‑management channel. Commercial channel revenue rose 22% to $12 million, powered by a 25% surge in...
Researchers have engineered ligand‑conjugated mRNA‑lipid nanoparticles that home specifically to the endometrium, delivering therapeutic mRNA directly to uterine tissue. In a murine model of endometrial injury, the targeted formulation restored embryo implantation rates to near‑normal levels. Safety profiling showed reduced...
